Compare Stocks → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:PIII Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePIIIP3 Health Partners$0.45-7.0%$0.86$0.44▼$5.56$140.96M1.04379,243 shs469,400 shsBeginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePIIIP3 Health Partners0.00%-11.75%-56.68%-63.12%-64.87%These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free CopyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPIIIP3 Health Partners1.3341 of 5 stars3.32.00.00.00.60.81.3Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePIIIP3 Health Partners2.50Moderate Buy$4.75964.55% UpsideCurrent Analyst RatingsLatest PIII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/1/2024PIIIP3 Health PartnersWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform4/1/2024PIIIP3 Health PartnersBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral3/14/2024PIIIP3 Health PartnersLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$9.00 ➝ $4.50(Data available from 4/29/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPIIIP3 Health Partners$1.27B0.11$0.09 per share4.74$0.45 per share0.99Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePIIIP3 Health Partners-$57.77M-$0.65N/AN/AN/A-4.56%-120.85%-6.54%5/8/2024 (Estimated)Latest PIII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024Q4 2023PIIIP3 Health Partners-$0.19-$0.22-$0.03-$0.22$309.80 million$346.86 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPIIIP3 Health PartnersN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPIIIP3 Health Partners0.760.550.55OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPIIIP3 Health Partners7.75%Insider OwnershipCompanyInsider OwnershipPIIIP3 Health Partners17.06%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionablePIIIP3 Health Partners400315.90 million262.01 millionNot OptionablePIII HeadlinesSourceHeadlineCareRx (OTCMKTS:CHHHF) versus P3 Health Partners (NASDAQ:PIII) Financial Surveyamericanbankingnews.com - April 19 at 1:16 AMP3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conferencebusinesswire.com - April 3 at 8:00 AMWilliam Blair Analysts Reduce Earnings Estimates for P3 Health Partners Inc. (NASDAQ:PIII)marketbeat.com - April 3 at 6:00 AMEquities Analysts Set Expectations for P3 Health Partners Inc.'s Q1 2025 Earnings (NASDAQ:PIII)marketbeat.com - April 2 at 6:38 AMP3 Health Partners (NASDAQ:PIII) Earns Outperform Rating from William Blairmarketbeat.com - April 1 at 5:26 PMP3 Health Partners (NASDAQ:PIII) Rating Lowered to Neutral at BTIG Researchmarketbeat.com - April 1 at 8:29 AMP3 Health Partners: Q4 Earnings Insightsbenzinga.com - March 28 at 7:59 PMP3 Health Partners Inc. Reports Revenue Growth and Affirms 2024 Guidance, Despite Net Lossfinance.yahoo.com - March 28 at 7:59 PMP3 Health Partners Announces Fourth Quarter and Full Year 2023 Resultsbusinesswire.com - March 28 at 4:05 PMP3 Health to report Q4 and full year 2023 earnings on March 28uk.investing.com - March 17 at 3:04 PMP3 Health Partners to Participate in the Jefferies Value Based Healthcare Summitbusinesswire.com - February 28 at 8:00 AMP3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conferencebusinesswire.com - February 19 at 8:00 AMP3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conferencefinance.yahoo.com - January 30 at 12:51 PMP3 Health Partners Inc.'s (NASDAQ:PIII) Path To Profitabilityfinance.yahoo.com - January 19 at 8:47 AMP3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimatesmsn.com - January 10 at 6:58 AMWhy Health Management Company P3 Health Partners Shares Are Up Todaymarkets.businessinsider.com - January 10 at 6:58 AMP3 Health Partners Reaffirms 2023 Guidance, Sees 2024 Revenue Above View; Stock Upmarkets.businessinsider.com - January 9 at 10:43 PMP3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024finance.yahoo.com - January 9 at 10:43 PMP3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 2 at 5:49 PMBTIG Research initates P3 Health Partners Inc (PIII) rating to a Buyknoxdaily.com - January 1 at 8:03 PMP3 Health Partners Inc Class A PIIImorningstar.com - December 17 at 1:39 AMPositive Revenue Prospects and Improved Cash Flow: Reasons Behind David Larsen’s Buy Rating for P3 Health Partnersmarkets.businessinsider.com - November 15 at 12:04 AMP3 Health Partners Inc. (NASDAQ:PIII) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 12 at 1:24 PMP3 Health Partners Inc [PIII] Records 50-Day SMA of $1.7013knoxdaily.com - November 10 at 8:42 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsP3 Health PartnersNASDAQ:PIIIP3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
